Evidence map›Paper›PMID 32474886›Full record

ArticleClinical rheumatology2020

Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.

Frank Behrens, Hans-Peter Tony, Michaela Koehm, Eva C Schwaneck, Holger Gnann, Gerd Greger, Harald Burkhardt, Marc Schmalzing

Abstract readPublished Erratum
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Frank BehrensDivision of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Hans-Peter TonySchwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Oberdürrbacher Strasse 6, Würzburg, Germany.
Michaela KoehmDivision of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Eva C SchwaneckSchwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Oberdürrbacher Strasse 6, Würzburg, Germany.
Holger GnannAbteilung Biostatistik, GKM Gesellschaft für Therapieforschung mbH, Munich, Germany.
Gerd GregerAbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
Harald BurkhardtDivision of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Marc SchmalzingSchwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Oberdürrbacher Strasse 6, Würzburg, Germany. Schmalzing_M@ukw.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this article was published without open access. With the author(s)' decision to opt for Open Choice the copyright of the article changed.].

Identifiers

PMID32474886
PMCPMC7338815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.